Adding CD47 to Artificial Antigen-Presenting Cells May Stimulate T-Cell Responses and Improve Functionality

Get Permission

Artificial antigen-presenting cells have been shown to stimulate antigen-specific T-cell responses, but their effect in vivo may be compromised by rapid macrophage clearance. In a study reported in Clinical Cancer Research, Bruns and colleagues added CD47 to classic two-signal artificial antigen-presenting cells to produce a three-signal “don’t eat me” artificial antigen-presenting cell that might better avoid macrophage uptake and clearance. 

Control artificial antigen-presenting cells and the CD47-positive antigen-presenting cells were analyzed in vitro in human primary T-cell and macrophage co-cultures and compared in vivo in a NOD/SCID T-cell proliferation model and a B16-SIY melanoma model. In culture with human macrophages, CD47-positive antigen-presenting cells exhibited CD47 concentration-dependent inhibition of phagocytosis with no reduction in their ability to generate and expand antigen-specific T cells; the T cells generated by these antigen-presenting cells had killing abilities and polyfunctionality equivalent to those of control antigen-presenting cell–generated T cells. In in vivo studies, CD47-positive antigen-presenting cells exhibited increased stimulatory capacity and tumor inhibition compared with control antigen-presenting cells.

The investigators concluded: “Our data for the first time show that [artificial] antigen-presenting cells functionalized with CD47 maintain their stimulatory capacity in vitro and demonstrate enhanced in vivo efficiency. Thus, this next generation [artificial] APCCD47+ has a unique potential to enhance the application of the [artificial] antigen-presenting cell technology for future immunotherapy approaches.” ■

Bruns H, et al: Clin Cancer Res. January 15, 2015 (early release online).




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.